✦ LIBER ✦

THE 2.25 MILLIMETER XIENCE V® EVEROLIMUS ELUTING CORONARY STENT SYSTEM FOR THE TREATMENT OF SMALL CORONARY ARTERIES: THE SPIRIT SMALL VESSEL TRIAL

✍ Scribed by Costa, Marco A.; Jones, Jennifer; Fleischhauer, F. James; Cheong, Wai-Fung; Kusano, Hajime; Farhat, Naim; Wang, Jin; Lombardi, William; Zhang, Zhen; Maddux, James; Mego, David; Li, Xiaolin; Cannon, Louis; Hattori, Kyoko; Foster, Malcolm T.; Sood, Poornima; Simon, Daniel

Book ID: 122381520
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 119 KB
Volume: 57
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(11)61690-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The XIENCE nano™ everolimus eluting coro

The XIENCE nano™ everolimus eluting coronary stent system for the treatment of small coronary arteries: The SPIRIT small vessel trial

✍ Louis A. Cannon; Daniel I. Simon; Dean Kereiakes; Jennifer Jones; Roxana Mehran; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

PERFORMANCE OF XIENCE V EVEROLIMUS-ELUTI

PERFORMANCE OF XIENCE V EVEROLIMUS-ELUTING VS. TAXUS EXPRESS PACLITAXEL-ELUTING CORONARY STENTS IN SMALL VESSELS: POOLED RESULTS OF THE SPIRIT III AND SPIRIT IV CLINICAL TRIALS

✍ Hermiller, James Bernard; Applegate, Robert; Dootzadeh, Julie; Pierson, Wesley; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Pharmacokinetic Sub-Study in the SPIRIT

Pharmacokinetic Sub-Study in the SPIRIT III Randomized and Controlled Trial of XIENCE V® Everolimus Eluting Coronary Stent System

✍ QING WANG; WESLEY PIERSON; POORNIMA SOOD; CORNELIS BOL; LOUIS CANNON; PAUL GORDO 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

An everolimus-eluting stent versus a pac

An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials

✍ Antonio L. Bartorelli; Patrick W. Serruys; Karine Miquel-Hébert; Shui Yu; Wes Pi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

Comparison of Everolimus-Eluting and Pac

Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention: The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials

✍ Dean J. Kereiakes; Krishnankutty Sudhir; James B. Hermiller; Paul C. Gordon; Joa 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 939 KB

Four-year clinical follow-up of the XIEN

Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial

✍ Scot Garg; Patrick W. Serruys; Karine Miquel-Hebert; on behalf of the SPIRIT II 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

## Abstract This report describes the 4‐year clinical outcomes of the SPIRIT II study, which randomized 300 patients to treatment with the XIENCE V everolimus‐eluting stent (EES), or the TAXUS paclitaxel‐eluting stent. At 4‐year clinical follow‐up, which was available in 256 (85.3%) patients, treat